Alzheimer's disease affects an estimated 6.7 million Americans, and Mississippi's aging population means this is an increasingly relevant concern for families across the state. One of the most common questions we hear from patients in their 40s and 50s: is there anything I can do now, while I still feel fine?
The answer is increasingly yes — not in the sense of a definitive diagnosis, but in the sense of understanding risk factors that are modifiable and identifying biological signals that research associates with Alzheimer's pathology.
What Is the AD-Detect™ Test?
Julep Health offers the AD-Detect™ test, a blood-based panel that measures beta-amyloid 42/40 ratio — a biomarker that research has linked to amyloid accumulation in the brain, one of the hallmark features of Alzheimer's pathology.
It is important to understand what this test is and what it isn't. AD-Detect™ is a risk awareness tool, not a diagnostic test. A result outside the reference range does not mean a patient has Alzheimer's disease or will develop it.
What it provides is one data point that, considered in the context of family history, cognitive symptoms, APOE gene status, and other risk factors, can inform a proactive conversation about brain health.
Physician-Guided Review
This test is most meaningfully used in the context of a physician-guided consultation — which is exactly how Julep Health approaches it. Dr. Briscoe reviews results with patients directly, provides clinical context for what the numbers mean, and discusses practical, evidence-informed steps for supporting long-term cognitive health, including metabolic optimization, cardiovascular risk reduction, sleep, and inflammation management.
Want to Be Proactive About Brain Health?
For patients who have a family history of Alzheimer's, who are noticing early memory changes, or who simply want to be proactive about cognitive health, this is a conversation worth having.
Book Your AppointmentJulep Health serves the Ridgeland, Madison, and Jackson area.